Skip to content

Our team

Prova Health is a global research and consultancy firm focused on accelerating the adoption of health innovation. We work across digital health and AI, pharma and diagnostics, helping innovators prove their value, navigate regulatory and reimbursement pathways, and get adopted by the health systems and markets that matter most.

Since 2020, we've grown into a team of experts spanning the UK and US, working with clients in all major markets. Our proprietary network of 600+ healthcare insiders across 40+ countries keeps our work grounded in how care is actually delivered.

  • Gianluca Fontana

    Chief Executive Officer & Co-founder

    Gianluca Fontana

    Gianluca is a co-founder of Prova Health and a health innovation expert who has supported pharmaceutical companies, digital health innovators and health systems in over 30 global markets. He oversees a wide range of our projects and leads our strategy and business development activities.

    Gianluca Fontana

    Chief Executive Officer & Co-founder

    Gianluca Fontana

    Gianluca is a health innovation expert that has supported pharmaceutical companies, digital health innovators and health systems in over 30 global markets. He leads Prova Health’s strategy and business development activities and oversees a wide range of our client projects. He previously was the Deputy Director of the Institute of Global Health Innovation at Imperial College London and a management consultant in the healthcare practice of McKinsey and Company, where he was a leader in McKinsey’s Health Systems Institute.

    Connect on LinkedIn
  • Dr Jack Halligan

    Chief Operating Officer & Co-founder

    Dr Jack Halligan

    Jack is a medical doctor and co-founder of Prova Health, where he leads a range of projects across digital health, diagnostics and pharma. He combines clinical experience with time at McKinsey & Company and in academia at Imperial College London.

    Dr Jack Halligan

    Chief Operating Officer & Co-founder

    Dr Jack Halligan

    Jack is a co-founder of Prova Health, where he has led dozens of projects with digital health, diagnostics and pharmaceutical clients, helping them to successfully commercialise healthcare innovations.

    Jack is a medical doctor who trained at the Royal College of Surgeons in Ireland and holds an MBA from INSEAD. Before founding Prova Health, he worked as a management consultant at McKinsey & Company, advising healthcare organisations on strategy and operations, and served as a Policy Fellow at Imperial College London's Institute of Global Health Innovation (IGHI), working closely with digital health innovators on research and policy projects.

    He has worked across clinical medicine, healthcare technology and consulting in Ireland, the UK, Australia and New Zealand.

    Connect on LinkedIn
  • Dr Saira Ghafur

    Chief Medical Officer & Co-founder

    Dr Saira Ghafur

    Saira is a practicing respiratory physician and health policy expert that provides clinical leadership to Prova Health’s projects

    Dr Saira Ghafur

    Chief Medical Officer & Co-founder

    Dr Saira Ghafur

    Saira is an honorary consultant Respiratory Physician at St Mary’s Hospital, London and digital health expert who has published on topics such as cybersecurity, digital health adoption and reimbursement, data privacy and commercialising health data. She is the co-founder of mental health start-up Psyma and holds a MSc in Health Policy from Imperial. Saira was also a Harkness Fellow in Health Policy and Practice in New York (2017).

    Connect on LinkedIn
  • Ryan Callahan

    Senior Director

    Ryan Callahan

    Ryan provides US-based expertise to our global clients and leads projects that bridge the gap between clinical best practice and real world challenges in adoption. He brings experience from hospital financial operations and strategy consulting at McKinsey.

    Ryan Callahan

    Senior Director

    Ryan Callahan

    Based in the US, Ryan serves clients who are bringing innovative products and services to North American and global markets. His work in commercialisation draws on his expertise in reimbursement, product development, and organisational leadership. As a strategy consultant at McKinsey & Company, he served leading companies in the pharmaceutical and medical device industries and brings experience working across teams and geographies to deliver results. Ryan’s work leverages quantitative methods with a significant focus on ROI, market sizing, and epidemiological analysis.

    Connect on LinkedIn
  • Dr Des Conroy

    Senior Consultant, Head of Capability Building

    Dr Des Conroy

    Des is Head of Capability Building at Prova Health, leading strategic consulting projects that help increase adoption of innovation in healthcare. He is a medical doctor with experience across clinical practice, digital health, and life sciences consulting.

    Dr Des Conroy

    Senior Consultant, Head of Capability Building

    Dr Des Conroy

    Des is Head of Capability Building at Prova Health, where he leads strategic consulting projects for global pharmaceutical, diagnostics, and digital health clients. His work helps increase adoption of innovation in clinical practice, with a focus on clinical pathways, commercial strategy, and capability building for commercial and medical teams. He has led programmes for some of the world's largest life sciences companies. Des is a medical doctor who combines practical insight and strategic thinking to bridge the gap between clinical, commercial, and health system perspectives.

    Connect on LinkedIn
  • Carmen Garcia Sebego

    Associate Consultant

    Carmen Garcia Sebego

    Carmen is an Associate Consultant at Prova Health, where she supports projects across Digital Health, Diagnostics and Pharmaceuticals. She holds a joint degree in Biochemistry and Management from Imperial College London and has experience in clinical trial strategy and medical devices.

    Carmen Garcia Sebego

    Associate Consultant

    Carmen Garcia Sebego

    Carmen is an Associate Consultant at Prova Health, where she supports projects across Digital Health, Diagnostics and Pharmaceuticals. She holds a joint degree in Biochemistry and Management from Imperial College London and has experience in clinical trial strategy and medical devices.

  • Claire Lynam

    Founders' Associate

    Claire Lynam

    Claire is the Founder's Associate at Prova Health, where she supports strategy, operations and business development across the firm. She brings experience as a health financing economist and a Master's in Development Economics from the University of Nottingham.

    Claire Lynam

    Founders' Associate

    Claire Lynam

    Claire is the Founder's Associate at Prova Health, working alongside the founders on the projects that matter most as the firm grows. Her role cuts across the business, from strategy and business development to finance, contracts and operational systems.

    Claire trained as an economist and spent years as a consultant at Genesis Analytics, advising governments and global funders across Africa, the Middle East and Asia on health financing. She holds a Master's in Development Economics from the University of Nottingham.

    Connect on LinkedIn
  • Dr Gareth Obery

    Senior Consultant, Head of Digital Health and AI

    Dr Gareth Obery

    Gareth is the Head of Digital Health and AI at Prova Health. He has a background as a South African-trained clinician and holds a Master’s in Applied Digital Health from the University of Oxford.

    Dr Gareth Obery

    Senior Consultant, Head of Digital Health and AI

    Dr Gareth Obery

    Gareth is the Head of Digital Health and AI at Prova Health, leading projects spanning evidence generation, health economics, regulation, and commercialisation, with a focus on demonstrating the value of health innovations. He brings a global health perspective, having trained and practised in the South African public healthcare sector. Gareth also holds a Master’s in Applied Digital Health from the University of Oxford, where he focused on risk prediction models.

    Connect on LinkedIn
  • Dr Samin Saeed

    Board Advisor

    Dr Samin Saeed

    Samin is an experienced global pharmaceutical leader with 18 years in the Pharma industry. Formerly Chief Medical Officer for a private-equity-backed pharma services firm, she has led medical teams and across diverse therapeutic areas.

    Dr Samin Saeed

    Board Advisor

    Dr Samin Saeed

    Sameen is an experienced global pharmaceutical leader with 18 years in the Pharma industry. Formerly Chief Medical Officer for a private-equity-backed pharma services firm, she has led medical teams and across diverse therapeutic areas. Samin joins Prova Health as an advisor to enable our mission to help pharma maximise the adoption and impact of their innovations.

    Connect on LinkedIn
  • Dr Iain Charlton

    Advisor, Regulation

    Dr Iain Charlton

    Iain has worked in medical devices and digital health for over 20 years and specialises in the regulation of Software as a Medical Device (SaMD).

    Dr Iain Charlton

    Advisor, Regulation

    Dr Iain Charlton

    Iain has worked in medical device and healthcare software for over 20 years, with experience across research, software development and QA/RA. He specialises in the regulation of SaMD, with particular interest in software development, AI, privacy and cybersecurity. He works with many early stage health technology startups to develop regulatory strategies for new products and prepare clearances for the UK, EU and US markets. He also holds a voluntary position on the board of the Biomedical Engineering Division at the IMechE.

    Connect on LinkedIn
  • Ed Dougherty

    Advisor, Regulatory and Reimbursement (US)

    Ed Dougherty

    Ed advises medical device, diagnostics, and digital health companies, as well as those developing AI-enabled diagnostics and therapeutics to develop actionable strategies for US marketing clearance or approval, rapid adoption, and reimbursement.

    Ed Dougherty

    Advisor, Regulatory and Reimbursement (US)

    Ed Dougherty

    Ed advises medical device, diagnostics, and digital health companies, as well as those developing AI-enabled diagnostics and therapeutics to develop actionable strategies for US marketing clearance or approval, rapid adoption, and reimbursement.

    For 30 years, Ed has worked directly with founders, company executives, board members, and investors to help them develop a strategic understanding of the many “healthcare markets” in the US and to prepare to take the concrete steps needed to enter these markets successfully. 

    He advises companies in the US, UK, EU, the Nordics, Israel, and South Korea, and has authored articles about health economics and served as contributing editor to publications on global market access.

    Connect on LinkedIn
  • Prof Stephen Gilbert

    Advisor, Regulation and Market Access

    Prof Stephen Gilbert

    Stephen teaches and conducts research on regulatory science. His research themes are on the intersection between pharmaceutical regulation and medical device regulation. He has worked in senior MedTech and Digital Heath roles in industry.

    Prof Stephen Gilbert

    Advisor, Regulation and Market Access

    Prof Stephen Gilbert

    Stephen teaches and conducts research on regulatory science. His research themes are on the intersection between pharmaceutical regulation and medical device regulation. He has worked in senior MedTech and Digital Heath roles in industry. Stephen is in close interaction with the EU and German authorities responsible for drafting laws, and the trade bodies reacting to law. He is an Expert Consultant to the European Commission on new legislative approaches. His daily academic work involves study of the landscape of developing EU and German legislation.

    Connect on LinkedIn
  • Maria Hovakimyan

    Advisor, Health Systems

    Maria Hovakimyan

    Maria Hovakimyan is an Advisor to Armenia’s Minister of Health and a health systems professional leading international partnerships for reforms in universal health coverage, quality of care, and health system strengthening.

    Maria Hovakimyan

    Advisor, Health Systems

    Maria Hovakimyan

    Maria Hovakimyan is an Advisor to the Minister of Health of Armenia with experience in universal health coverage, primary health care and e-health, and healthcare donor coordination. She holds an MSc in Global Health Policy from The London School of Economics and Political Science.

  • Adam Isaacs Rae

    Advisor, Regulation

    Adam Isaacs Rae

    Adam Isaacs Rae is Director of The Other Consultants, where the goal of the organisation is to help turn innovation into approved medical device products by shaping regulatory strategy through design control, clinical evidence, quality systems and certification.

    Adam Isaacs Rae

    Advisor, Regulation

    Adam Isaacs Rae

    Adam Isaacs Rae, who leads The Other Consultants has spent his career taking medical devices from concept to market. Recently voted as the 19th most leading voice in Global MedTech. He began in product development and quality at Thermo Fisher Scientific, Stryker and Siemens. Adam now operates as a strategic regulatory consultant partner within the medical device industry, focusing particularly on Software as a Medical Device (SaMD), Artificial Intelligence as a Medical Device (AIaMD) and ML enabled devices. Practically, this ensures design control, clinical evidence and technical files support successful approvals across UK MDR, EU MDR, IVDR and FDA pathways, securing and supporting registrations in markets across Asia, the Middle East and beyond. As well as working on the device side, Adam also has held ongoing assessment roles within the conformity assessment and certification space giving him a unique blend of both sides of the table. Furthermore, Adam is also a co-founder of a medical device company, giving him an understanding of all sides of the industry (development, assessment and approval). He has been involved in leading consultation responses, and in working groups with the MHRA on the approaches defining AI within the medical device industry.

  • Dr Ana Luisa Neves

    Advisor, Clinical Evidence

    Dr Ana Luisa Neves

    Ana is a medical doctor and PhD researcher with >15 years’ experience evaluating digital health solutions. She has published >40 papers in peer-reviewed journals.

    Dr Ana Luisa Neves

    Advisor, Clinical Evidence

    Dr Ana Luisa Neves

    Ana is a medical doctor and researcher with more than 15 years’ experience evaluating digital health solutions. Ana obtained a PhD in Clinical Medicine at Imperial College London and has published >40 papers in peer-reviewed journals (>3,000 citations). She is currently Director of the Global Digital Health Unit at Imperial College London and Associate Professor at the University of Porto.

    Connect on LinkedIn
  • Dr Martina Orlovic

    Advisor, Health Economics

    Dr Martina Orlovic

    Martina is a health economist with expertise in economic evaluation, market access and health policy.

    Dr Martina Orlovic

    Advisor, Health Economics

    Dr Martina Orlovic

    Martina is a health economist with expertise in economic evaluation, market access and health policy. She has over 10 years of experience in consulting and biotech companies. She is currently Global HEOR Director at argenx.  Martina holds a Bachelor and Master of Science degree in Business Economics (Finance) from the University of Zagreb, a Master’s in International Health Policy – Health Economics from LSE and a PhD in Clinical Medicine Research from Imperial College London.

    Connect on LinkedIn
  • Dr Mehul Patel

    Advisor, Digital Health and AI

    Dr Mehul Patel

    Mehul is a practising NHS General Practitioner with over 13 years of clinical experience and an MSc in Health Informatics from UCL/University of Manchester.

    Dr Mehul Patel

    Advisor, Digital Health and AI

    Dr Mehul Patel

    Mehul is a practising NHS General Practitioner with over 13 years of clinical experience and an MSc in Health Informatics from UCL/University of Manchester. He is also a Health Informatician who has worked in digital health both within the NHS and in industry, holding Clinical Lead and Clinical Safety roles for multiple digital health companies that have successfully scaled within the NHS.

    He has also completed a Health Education England Fellowship in Informatics, contributing to national-level informatics projects across the NHS.

    Mehul leads work with digital health and AI clients at Prova Health, with a focus on evidence generation projects that support the safe, effective, and scalable adoption of innovations.

  • Jonty Roland

    Advisor, Health Systems

    Jonty Roland

    Jonty is an independent adviser on health system reform and universal health coverage to governments, global institutions and private sector organisations.

    Jonty Roland

    Advisor, Health Systems

    Jonty Roland

    Jonty is an independent adviser on health system reform and universal health coverage to governments, global institutions and private sector organisations. He has experience of working in more than 25 countries supporting major health system reforms, as well as authoring award-winning global health thought leadership. He studies Management and Business at the University of Cambridge, and also has an MSc in Public Health from the London School of Hygiene and Tropical Medicine.

    Connect on LinkedIn
  • Dr Divya Srivastava

    Advisor, Economic Evidence

    Dr Divya Srivastava

    Divya is a health economist who leads the Digital Health Lab in The Centre for Healthcare Innovation Research at the University of London.

    Dr Divya Srivastava

    Advisor, Economic Evidence

    Dr Divya Srivastava

    Divya is a health economist with expertise in digital health technologies and comparative health policy. Divya is an Assistant Professor in Research Methods and leads the Digital Health Lab in The Centre for Healthcare Innovation Research at the University of London. Divya also holds a Visiting Senior Fellow position in the Department of Health Policy at the London School of Economics and Political Science.

    Connect on LinkedIn
  • Didi Thompson

    Advisor, Health Systems

    Didi Thompson

    Didi has worked across a range of healthcare and policy initiatives spanning research, consulting, and education at Imperial College London and McKinsey & Company.

    Didi Thompson

    Advisor, Health Systems

    Didi Thompson

    Didi has worked across a range of healthcare and policy initiatives spanning research, consulting, and education. She has held positions at Imperial College London, the World Innovation Summit for Health, McKinsey & Company, and The Advisory Board. Didi has an MSc in International Health Policy from the London School of Economics and Political Science, where she received the Brian Abel-Smith Prize for the best dissertation.

    Connect on LinkedIn
  • Susan Xu

    Advisor, Market Access (US)

    Susan Xu

    Susan is a US-based healthcare reimbursement and market access strategist with experience advising digital health companies on how to access the US market.

    Susan Xu

    Advisor, Market Access (US)

    Susan Xu

    Susan is a healthcare reimbursement strategist and author of the book titled “Healthcare’s Reimbursement Maze: Navigating Market Access for Medical Innovation in the US.” Her experience encompasses medical technology, health policy, and consulting.

    Connect on LinkedIn

Our purpose

Prova Health exists to improve health for all by accelerating the adoption of health innovation.

We believe that innovation in healthcare needs to be evidence-based, safe, effective and provide value for money. We act on these convictions by supporting the countless organisations and individuals that are trying to make healthcare better.

Our values

  • Trust

    Trust is at the core of everything we do. We want to build trust with our clients, partners and team members. We strengthen trust in health innovation. We keep our word when we commit to do something and we maintain high standards and an independent point of view.

  • Care 

    Care is what we want to give to the people we work and interact with. It is a necessity. To us, that means being thoughtful, kind, respectful and inclusive.

  • Excellence 

    Excellence is what we aspire to. At Prova Health we are ambitious. We want to tackle big challenges and do so globally. We are lucky to have incredibly innovative people and organisations as our clients. We are inspired by them to always push the boundaries of what we do.

  • Collaboration

    Collaboration is the only way we can achieve our purpose. We will not be able to do it alone. We practise collaboration within our team, we build strong relationships, as equal partners, with our clients and we create connections between the people we encounter that share our goals and beliefs.

Accelerate the adoption of your health innovation.

Get in touch